Search - tctmd.com

December 18, 2025

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

December 15, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

October 02, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

September 10, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

August 26, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

May 07, 2025

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

April 14, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

December 30, 2024

News Daily News

Female-Specific Factors Don’t Enhance Common Risk Calculators

December 10, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

July 29, 2024

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

July 03, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

April 17, 2024

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

April 09, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

February 01, 2024

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

December 19, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

December 06, 2023

News Daily News

Statin Use Has Plateaued in US Primary Prevention Patients